 |
|
| Heart Valve Summit — Faculty Disclosure/Conflict of Interest Statement |
|
Quick Links       AATS/ACCF faculty, committee members, staff and other individuals who are in a position to control the content of this activity are required to disclose all real or apparent conflicts of interest. All relevant potential conflicts of interest that are identified are thoroughly vetted through a process that includes course directors and appropriate peer review by education committee chairs/members for fair balance, scientific objectivity and validity, patient care and safety recommendations. Program Co- Directors David H. Adams, M.D., F.A.C.C.Marie-Josée and Henry R. Kravis Professor and Chairman Department of Cardiothoracic Surgery Mount Sinai Medical Center New York, NY Speaker is a Consultant and receives Royalties as an inventor for Edwards Lifesciences. Speaker does not plan on discussing unlabeled/investigational uses of a commercial product. Steven F. Bolling, M.D., F.A.C.C. Professor of Adult Cardiac Surgery University of Michigan Ann Arbor, MI Speaker receives Royalties from Edwards Lifesciences. Speaker does not plan on discussing unlabeled/investigational uses of a commercial product. Robert O. Bonow, M.D., M.A.C.C. Goldberg Distinguished Professor of Cardiology Chief, Division of Cardiology Northwestern University Feinberg School of Medicine Chicago, IL Speaker is a Consultant for Edwards Lifesciences. Speaker does not plan on discussing unlabeled/investigational uses of a commercial product. Howard C. Herrmann, M.D., F.A.C.C. Director, Cardiac Catheterization Labs University of Pennsylvania Medical Center Philadelphia, PA Speaker receives Grant/Research Support from Edwards Lifesciences and Evalve. Speaker is a Stockholder of Endovalve. Speaker plans on discussing unlabeled/investigational uses of a commercial product and will disclose this to the audience. Nurse Planner: Anelechi Anyanwu, M.D. Associate Professor, Department of Cardiothoracic Surgery Mount Sinai Medical Center New York, NY Speaker has nothing to disclose with regard to commcercial support. Speaker does not plan on discussing unlabeled/investigational uses of a commercial product. Catherine Bingham, NP Department of Cardiothoracic Surgery Mount Sinai Medical Center New York, NY Speaker has nothing to disclose with regard to commercial support. Speaker does not plan on discussing unlabeled/investigational uses of a commerical product. Jeffrey S. Borer, M.D., F.A.C.C. Director, Howard Gilman Institute of Valvular Heart Diseases Chief, Division of Cardiovascular Medicine State University of New York (SUNY) Downstate Medical Center Brooklyn, NY Speaker is a Consultant for Servier, BioMarin and ARMGO. Speaker is CBC for Pfizer and DMC for ARMGO, Merck, Celladon and Novartis. Speaker is a minor Stockholder of Metronic. Speaker does not plan on discussing unlabeled/investigational uses of a commercial product. Eugene Braunwald, M.D., F.A.C.C. Distinguished Hersey Professor of Medicine, Harvard School of Medicine Chairman, TIMI Study Group Brigham & Women's Hospital Boston, MA Speaker is a Consultant, member of the Advisory Board, and receives Honoraria from the following companies: Bayer AG, CV Therapeutics, Daiichi Sankyo, Eli Lilly, Merck & Co., Momenta, Schering-Plough, sanofi-aventis, Cytokinetics, Genzyme, GlaxoSmithKline, Broadview Ventures. Speaker is the Chairman of the TIMI Study Group at the Brigham and Women’s Hospital. The Brigham and Women’s Hospital receives (or has received within the past 24 months) Grant Support for the TIMI Study Group from the following pharmaceutical companies (all > $10,000): AstraZeneca Pharmaceuticals LP, Johnson & Johnson, Beckman Coulter, Inc., Bristol Myers Squibb Pharmaceutical Research Institute, CV Therapeutics, Eli Lilly, Genentech, Integrated Therapeutics Group, Merck & Co., Inc., Novartis, Roche Diagnostics Corp., sanofi aventis, Schering Plough Research Institute, Daiichi Sankyo and Eisai Medical Research. Speaker plans on discussing unlabeled/investigational uses of a commercial product and will disclose this to the audience. Maurice Buchbinder, M.D., C.M., F.A.C.C. San Diego Cardiovascular Associates San Diego, CA Speaker is a Consultant and Stockholder of Medtronic, Boston Scientific, Abbott, Cordis. Speaker does not plan on discussing unlabeled/investigational uses of a commercial product. Blasé A. Carabello, M.D., F.A.C.C. Professor of Medicine Baylor Medical Center Houston, TX Speaker has nothing to disclose with regard to commcercial support. Speaker does not plan on discussing unlabeled/investigational uses of a commercial product. Joseph S. Coselli, M.D., F.A.C.C. Chief, Division of Cardiothoracic Surgery Baylor College of Medicine Houston, TX Speaker is a Principal Investigator for Trifecta AV- St. Jude Medical, Cook, Inc. and Medtronic, Inc. Speaker is a Consultant for Medtronic, Inc., Vaskutek Terumo and Edwards Life Sciences, receives Grant/Research Support from Vaskutek Terumo and a member of the Speakers Bureau for Medtronic, Inc. and W.L. Gore & Associates, Inc. Speaker plans on discussing unlabeled/investigational uses of a commercial product and will disclose this to the audience. Tirone E. David, M.D., F.A.C.C. Professor of Surgery University of Toronto Toronto, Canada Speaker has nothing to disclose with regard to commcercial support. Speaker does not plan on discussing unlabeled/investigational uses of a commercial product. Deborah Jefferson, R.N., A.P.N., M.H.A. Clinical Nurse Children’s Memorial Hospital Chicago, IL Speaker has nothing to disclose with regard to commcercial support. Speaker does not plan on discussing unlabeled/investigational uses of a commercial product. Roberto R. Lang, M.D., F.A.C.C., F.A.S.E. Professor of Medicine Director, Noninvasive Cardiac Imaging Lab University of Chicago Medical Center Chicago, IL Speaker is a member of the Speakers Bureau for Philips Ultrasound. Speaker does not plan on discussing unlabeled/investigational uses of a commercial product. Randolph P. Martin, M.D., F.A.C.C., F.A.S.E. Professor of Medicine Director of Noninvasive Cardiology Emory University Atlanta, GA Speaker is a Moderator for Edwards and Novartis. Speaker does not plan on discussing unlabeled/investigational uses of a commercial product. Patrick M. McCarthy, M.D., F.A.C.C. Professor of Surgery, Co-Director of Bluhm Cardiovascular Institute Chief of the Division of Cardiothoracic Surgery Northwestern Memorial Hospital Chicago, IL Speaker is a Consultant for and receives Royalties from Edwards Lifesciences. Speaker does not plan on discussing unlabeled/investigational uses of a commercial product. D. Craig Miller, M.D. Thelma and Henry Dodge Professor of Cardiovascular Surgery Stanford University Medical School Stanford, CA Speaker is a Consultant for Medtronic Heart Valve Division, Inc. and St. Jude Medical. Speaker receives R01 Research Grant support from NHLBI, National Institutes of Health HL67025 & HL29589. Speaker is a member of the Executive Committee, PARTNER U.S. Trial-Percutaneous AVR, Edwards Lifesciences, LLP. Speaker does not plan on discussing unlabeled/investigational uses of a commercial product. Gail M. Osterman, PhD Assistant Professor of Psychiatry, Surgery Northwestern Memorial Hospital Chicago, IL Speaker has nothing to disclose with regard to commcercial support. Speaker does not plan on discussing unlabeled/investigational uses of a commercial product. Hyde Russell, M.D. Division of Cardiothoracic Surgery Children’s Memorial Hospital Chicago, IL Speaker has nothing to disclose with regard to commcercial support. Speaker does not plan on discussing unlabeled/investigational uses of a commercial product. Craig R. Smith, M.D. Chief, Division of Cardiothoracic Surgery College of Physicians and Surgeons of Columbia University New York, NY Speaker is a Principal Investigator for Edwards Lifesciences Partner Trial. Speaker plans on discussing unlabeled/investigational uses of a commercial product Sapien Valve and will disclose this to the audience. Allan S. Stewart, M.D. Assistant Professor of Surgery Columbia University New York, NY Speaker has nothing to disclose with regard to commcercial support. Speaker plans on discussing unlabeled/investigational uses of a commercial product; combination of 3F valve and Vascutek Valsalva Graft to create bioroot and will disclose this to the audience. Lissa Sugeng, M.D., F.A.C.C. Assistant Professor of Medicine University of Chicago Medical Center Chicago, IL Speaker is a Consultant and member of the Speakers Bureau for Philips Medical Imaging and receives Grant/Research Support and Software from TomTec Imaging Systems. Speaker does not plan on discussing unlabeled/investigational uses of a commerical product. Julie Swain, M.D., F.A.C.S. Cardiovascular Surgery Consultant Food and Drug Administration La Jolla, CA Speaker has nothing to disclose with regard to commcercial support. Speaker does not plan on discussing unlabeled/investigational uses of a commercial product. Mani Vannan, M.B.B.S., F.A.C.C. Professor of Clinical Internal Medicine Ohio State University Medical Center Columbus, OH Speaker is a member of the Speakers Bureau and receives Grant/Research Support from Siemens. Speaker plans on discussing unlabeled/investigational uses of a commercial product; 3-D Echo Software and will disclose this to the audience. ACC/AATS Staff Disclosures: AATS/ACCF staff have nothing to disclose with regard to commercial support. |
We Model Excellence |
 |
Copyright © American Association for Thoracic Surgery. All rights reserved.
Read the Privacy Policy.
IMPORTANT REMINDER: The preceding information is intended only to provide
general guidance and not as a definitive basis for diagnosis or treatment in any particular case.
It is very important that you consult a doctor about any specific medical problem or question.
Read the Privacy Policy.
IMPORTANT REMINDER: The preceding information is intended only to provide
general guidance and not as a definitive basis for diagnosis or treatment in any particular case.
It is very important that you consult a doctor about any specific medical problem or question.